Flemming Ørnskov
Flemming Ørnskov is the CEO of Galderma, a global dermatology company that has gained attention for its innovative biopharmaceuticals, including the recently approved therapeutic drug Nemluvio. Ørnskov has a strong background in the pharmaceutical industry, having previously held leadership roles at Shire, and is focused on successfully bringing new treatments to market while navigating the complexities of a rapidly evolving healthcare landscape.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Flemming Ørnskov is the CEO of Galderma and has high expectations for the new drug Nemluvio.
7